Every Form 4 that RANGE IMPACT INC (RNGE) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow RNGE and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RNGE filings page.
RANGE IMPACT, INC. director Celeste Richard F exercised stock options to acquire 250,000 shares of Common Stock. The options were exercised at a price of $0.1500 per share, and following the transaction she directly holds 250,000 Common Stock shares. The exercised award covered 250,000 option shares that were originally granted under an Option under Stock Incentive Plan with a conversion or exercise price of $0.1500 and an expiration date of December 31, 2035.
Range Impact, Inc. director Edward F. Feighan reported a new equity award in the form of stock options. On December 31, 2025, he was granted options to purchase 250,000 shares of common stock at an exercise price of $0.15 per share, with the option vesting immediately. Following this grant, he beneficially owned stock options relating to 2,333,000 derivative securities in total, all held directly. This reflects an incentive-based compensation grant rather than a market purchase or sale of existing shares.
Range Impact, Inc.'s Chief Financial Officer, Patricia Ann Missal, reported a new stock option grant. On December 31, 2025, she was granted options to purchase 150,000 shares of common stock at an exercise price of $0.15 per share, and the option vested immediately. Following this grant, she beneficially owned 400,000 derivative securities related to the company’s common stock in direct ownership.
Range Impact, Inc. disclosed that Chief Executive Officer and director Michael R. Cavanaugh received a new stock option grant. On December 31, 2025, he was granted options to purchase 250,000 shares of Range Impact common stock at an exercise price of $0.15 per share, and the option vested immediately.
Following this grant, Cavanaugh beneficially owned 3,350,000 derivative securities related to the company on a direct basis. Because the award vests right away and is struck at a fixed price, its value to the executive will depend on how Range Impact’s stock price compares to the $0.15 exercise price in the future.
Range Impact, Inc. director Richard F. Celeste received a grant of stock options for 250,000 shares of common stock. The options were granted on December 31, 2025 at an exercise price of $0.15 per share and vested immediately, meaning they were fully exercisable on the grant date. Following this award, Celeste beneficially owned 1,750,000 derivative securities related to Range Impact, all held in direct ownership form.
Joseph E. LoConti, a director of Range Impact, Inc. (RNGE), reported an insider purchase on 09/23/2025. He acquired 2,333,333 shares of common stock at $0.15 per share, increasing his reported indirect beneficial ownership to 19,130,479 shares through entities including Tower IV, LLC, Paragon Small Cap Fund LP, 4260 Winchell Road and the Joseph E. LoConti Revocable Trust.
Edward F. Feighan, a director of Range Impact, Inc. (RNGE), purchased 666,667 shares of Common Stock on 09/23/2025 at $0.15 per share. Following the reported transaction, the filing shows 3,732,356 shares beneficially owned directly by Mr. Feighan and an additional 685,228 shares held indirectly by The Feighan Family Fund LLC, of which he is the beneficial owner. The Form 4 is dated and signed 09/25/2025 and does not report any derivative transactions.
Range Impact, Inc. insider purchase reported. Chief Executive Officer and director Michael R. Cavanaugh bought 666,667 shares of Range Impact, Inc. (RNGE) on 09/23/2025 at a reported price of $0.15 per share, bringing his beneficial ownership to 2,546,458 shares. The filing is a Form 4 disclosing this non-derivative acquisition by an officer and director.